dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Wang, Shixiong |
dc.contributor.author | Somisetty, Venkata S. |
dc.contributor.author | Bai, Baoyan |
dc.contributor.author | Chernukhin, Igor |
dc.contributor.author | Niskanen, Henri |
dc.contributor.author | Kaikkonen, Minna U. |
dc.contributor.author | Bellet Ezquerra, Meritxell |
dc.date.accessioned | 2021-11-09T11:50:15Z |
dc.date.available | 2021-11-09T11:50:15Z |
dc.date.issued | 2020-10 |
dc.identifier.citation | Wang S, Somisetty VS, Bai B, Chernukhin I, Niskanen H, Kaikkonen MU, et al. The proapoptotic gene interferon regulatory factor-1 mediates the antiproliferative outcome of paired box 2 gene and tamoxifen. Oncogene. 2020 Oct 1;39(40):6300–12. |
dc.identifier.issn | 1476-5594 |
dc.identifier.uri | https://hdl.handle.net/11351/6516 |
dc.description | Càncer de mama; Marcadors pronòstics |
dc.language.iso | eng |
dc.publisher | Springer Nature |
dc.relation.ispartofseries | Oncogene;39(40) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Mama - Càncer - Tractament |
dc.subject | Regulació genètica |
dc.subject.mesh | Breast Neoplasms |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Gene Expression Regulation, Neoplastic |
dc.title | The proapoptotic gene interferon regulatory factor-1 mediates the antiproliferative outcome of paired box 2 gene and tamoxifen |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41388-020-01435-4 |
dc.subject.decs | neoplasias de la mama |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | regulación de la expresión génica neoplásica |
dc.relation.publishversion | https://doi.org/10.1038/s41388-020-01435-4 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Wang S, Somisetty VS, Bai B] Cell Cycle Regulations Group, Nordic EMBL Partnership, Centre for Molecular Medicine Norway (NCMM), University of Oslo, Blindern, P.O. 1137, 0318 Oslo, Norway. [Chernukhin I] Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. [Niskanen H, Kaikkonen MU] A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, PO Box 1627, 70211 Kuopio, Finland. [Bellet M] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 32843722 |
dc.identifier.wos | 000562669100001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |